What will the FDA discuss at the August 2026 drug repurposing meeting?

The FDA’s August 5, 2026 public meeting will focus on how to select and prioritize already approved drugs for potential new uses. Hosted by the Reagan-Udall Foundation, it will review input from a recent Request for Information and explore frameworks for identifying repurposing targets based on unmet medical need and public health impact.